Literature DB >> 6230124

Separation of immunoreactive lymphocytes from human pluripotent stem cells (CFU-GEMM) by means of counterflow centrifugation.

T de Witte, E Koekman, E Geestman, A Plas, G Blankenborg, J Wessels, C Haanen.   

Abstract

Counterflow centrifugation with continuous monitoring of the output for cell number and cell scatter was used to separate low density (d less than 1.070 g/ml) human bone marrow cells in two fractions: one containing the majority of small size lymphocytes and the other the majority of the larger sized committed progenitor cells. The recovery of the pluripotent stem cells (CFU-GEMM) in the large cell fraction was complete. The mitogenic reactivity of this putative stem cell fraction had decreased to 6% and 11%, of the original value as measured with phytohemagglutinin stimulation and one way mixed lymphocytic culture respectively. Counterflow centrifugation offers a physical separation technique, by which the majority of the immunoreactive cells can be separated from the pluripotent hematopoietic stem cells.

Entities:  

Mesh:

Year:  1984        PMID: 6230124     DOI: 10.1007/bf00320336

Source DB:  PubMed          Journal:  Blut        ISSN: 0006-5242


  18 in total

1.  Bone marrow transplantation in patients with acute leukaemia.

Authors:  H Abu-Zahra; D Amato; M T Aye; D E Bergsagel; A M Clarysse; D H Cowan; V L Fornasier; R Hasselback; N N Iscove; E A McCulloch; H Messner; R G Miller; R A Phillips; A H Ragab; W D Rider; J S Senn
Journal:  Ser Haematol       Date:  1972

2.  Erythroid colony formation in cultures of mouse and human bone marrow: analysis of the requirement for erythropoietin by gel filtration and affinity chromatography on agarose-concanavalin A.

Authors:  N N Iscove; F Sieber; K H Winterhalter
Journal:  J Cell Physiol       Date:  1974-04       Impact factor: 6.384

3.  Allogeneic bone marrow transplantation using stem cells fractionated by lectins: VI, in vitro analysis of human and monkey bone marrow cells fractionated by sheep red blood cells and soybean agglutinin.

Authors:  Y Reisner; N Kapoor; R J O'Reilly; R A Good
Journal:  Lancet       Date:  1980 Dec 20-27       Impact factor: 79.321

4.  The use of stem cell concentrates as bone marrow grafts in man.

Authors:  K A Dicke; U W Schaefer; D W van Bekkum
Journal:  Transplant Proc       Date:  1973-03       Impact factor: 1.066

5.  Monocyte purification with counterflow centrifugation monitored by continuous flow cytometry.

Authors:  P H De Mulder; J M Wessels; D A Rosenbrand; J B Smeulders; D J Wagener; C Haanen
Journal:  J Immunol Methods       Date:  1981       Impact factor: 2.303

6.  The influence of splenectomy on the invitro lymphocyte response to phytohemagglutinin and pokeweed mitogen in Hodgkin's disease.

Authors:  D J Wagener; E Geestman; H M Wessels
Journal:  Cancer       Date:  1975-07       Impact factor: 6.860

7.  Studies of human pluripotential hemopoietic stem cells (CFU-GEMM) in vitro.

Authors:  R C Ash; D A Detrick; E D Zanjani
Journal:  Blood       Date:  1981-08       Impact factor: 22.113

8.  Isolation of human T and B lymphocytes by rosette formation with 2-aminoethylisothiquronium bromide (AET) -treated sheep red blood cells with monkey red blood cells.

Authors:  M A Pellegrino; S Ferrone; A N Theofilopoulos
Journal:  J Immunol Methods       Date:  1976       Impact factor: 2.303

9.  Existence of a pool of T-lymphocyte colony-forming cells (T-CFC) in human bone marrow and their place in the differentiation of the T-lymphocyte lineage.

Authors:  F Triebel; W A Robinson; A R Hayward; P G Goube de Laforest
Journal:  Blood       Date:  1981-11       Impact factor: 22.113

10.  Separation of normal human bone marrow cells by counterflow centrifugal elutriation. I. Morphological analysis and subfractionation of neutrophilic granulocytes.

Authors:  F L Meyskens; C A Kiefer; D K Holmes; E W Gerner
Journal:  Exp Hematol       Date:  1979-09       Impact factor: 3.084

View more
  1 in total

1.  The role of CFU-GEMM in human hemopoiesis.

Authors:  H A Messner
Journal:  Blut       Date:  1986-10
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.